Literature DB >> 14770269

Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma.

Halina Kusnierczyk1, Elzbieta Pajtasz-Piasecka, Jan-Willem Koten, Caspaar Bijleveld, Krzysztof Krawczyk, Willem Den Otter.   

Abstract

We have compared the effect of one and up to four local IL-2 treatments of transplanted MC38 colon carcinoma. A single IL-2 treatment prolonged the survival time ( p=0.015), but no cure was obtained. One local IL-2 treatment inhibited tumor growth for about 1 week. After the start of tumor regrowth, a further IL-2 injection was given. After four IL-2 injections 6 out of 13 mice were cured. Histological studies show that IL-2 induced a local vascular leakage syndrome leading to massive peritumoral edema and subsequent necrosis of tumor tissue. IL-2 also attracted infiltrating cells, mainly macrophages. Subsequent IL-2 injections led to complete tumor regression. We believe that the combination of necrotic tumor debris and the IL-2-induced macrophage reaction enhanced a tumor-specific immune response. This local IL-2 application was not toxic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770269     DOI: 10.1007/s00262-003-0490-8

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  6 in total

1.  Locoregional IL-2 low dose applications for gastrointestinal tumors.

Authors:  Zachary Krastev; V Koltchakov; R Tomova; S Deredjian; A Alexiev; D Popov; B Tomov; Jan-Willem Koten; John Jacobs; Willem Den Otter
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

2.  Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer.

Authors:  Elena Niccolai; Edda Russo; Simone Baldi; Federica Ricci; Giulia Nannini; Matteo Pedone; Francesco Claudio Stingo; Antonio Taddei; Maria Novella Ringressi; Paolo Bechi; Alessio Mengoni; Renato Fani; Giovanni Bacci; Camilla Fagorzi; Carolina Chiellini; Domenico Prisco; Matteo Ramazzotti; Amedeo Amedei
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

3.  Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition.

Authors:  Antonela Del Giúdice; Lucas Pagura; María Celeste Capitani; Leandro Ernesto Mainetti; O Graciela Scharovsky; Ricardo José Di Masso; María José Rico; Viviana Rosa Rozados
Journal:  Future Sci OA       Date:  2020-10-27

4.  Local therapy of cancer with free IL-2.

Authors:  Willem Den Otter; John J L Jacobs; Jan J Battermann; Gerrit Jan Hordijk; Zachary Krastev; Ekaterina V Moiseeva; Rachel J E Stewart; Paul G P M Ziekman; Jan Willem Koten
Journal:  Cancer Immunol Immunother       Date:  2008-07       Impact factor: 6.968

5.  Anti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter.

Authors:  Yan Wang; Mengchun Wang; Yan Li
Journal:  Onco Targets Ther       Date:  2016-05-30       Impact factor: 4.147

6.  Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties.

Authors:  Elsa Jacouton; Marie-Laure Michel; Edgar Torres-Maravilla; Florian Chain; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  Front Microbiol       Date:  2019-01-11       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.